Crestwood Advisors Group LLC Has $75.82 Million Holdings in Danaher Co. (NYSE:DHR)

Crestwood Advisors Group LLC decreased its holdings in Danaher Co. (NYSE:DHR) by 0.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 330,306 shares of the conglomerate’s stock after selling 2,942 shares during the period. Danaher comprises about 1.4% of Crestwood Advisors Group LLC’s portfolio, making the stock its 18th biggest holding. Crestwood Advisors Group LLC’s holdings in Danaher were worth $75,822,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in DHR. AMF Tjanstepension AB acquired a new position in shares of Danaher in the third quarter worth $5,923,000. Howard Capital Management Group LLC lifted its holdings in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares during the last quarter. Dakota Wealth Management grew its stake in shares of Danaher by 1.0% in the 3rd quarter. Dakota Wealth Management now owns 8,161 shares of the conglomerate’s stock valued at $2,269,000 after buying an additional 82 shares in the last quarter. Allworth Financial LP raised its position in Danaher by 6.1% during the third quarter. Allworth Financial LP now owns 5,337 shares of the conglomerate’s stock valued at $1,484,000 after acquiring an additional 307 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in Danaher by 3.8% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 79,222 shares of the conglomerate’s stock worth $21,821,000 after acquiring an additional 2,879 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DHR. Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Citigroup lowered their price objective on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Jefferies Financial Group dropped their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Finally, Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research note on Friday, December 13th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 11.10% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $209.86 on Monday. The company has a fifty day moving average price of $226.71 and a 200-day moving average price of $246.84. The firm has a market cap of $149.99 billion, a price-to-earnings ratio of 39.75, a PEG ratio of 2.66 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company posted $2.09 EPS. As a group, equities research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.